BIO-CANCER TREATMENT
Bio-Cancer Treatment, founded in 2000, is a clinical-stage biopharmaceutical company focused on the research and development of innovative biologics for the treatment of human malignancies and auto-immune disorders. The company's product candidate portfolio comprises BCT-100 and BCT-200, both pegylated recombinant human arginase 1 (pegArg1), are arginine depleting agents that retard tumor growth and ultimately cancer death. BCT-100 is currently in phase I clinical trial in the US for the treatment of arginine-auxotrophic solid cancers and phase II clinical trial in Hong Kong for the treatment of acute myeloid leukemia (AML). BCT-200, with modifications to the BCT-100 amino acid sequence, is at the pre-IND stage.
BIO-CANCER TREATMENT
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Sha Tin, New Territories, Hong Kong
Country:
Hong Kong
Website Url:
http://www.bio-cancer.com
Status:
Active
Contact:
(852) 2521 1566
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx PHP Contact Form 7
Similar Organizations
Lasting Effect Pharma
Lasting Effect is an Israeli pharma startup. R&D Company dedicated to research, formulation, patenting the implementation of its technology.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.bio-cancer.com
- Host name: 45.121.197.59
- IP address: 45.121.197.59
- Location: Hong Kong
- Latitude: 22.25
- Longitude: 114.1667
- Timezone: Asia/Hong_Kong
